The Cholangiocarcinoma Foundation will be hosting educational and awareness activities in Chicago during the month of October.

HERRIMAN, UT, UNITED STATES, October 4, 2019 /EINPresswire.com/ -- FOR IMMEDIATE RELEASE:

The mission of the Cholangiocarcinoma Foundation (CCF) is to find a cure and improve the quality of life for those affected by cholangiocarcinoma (bile duct cancer). Founded in 2006 by a family member who lost a loved one to cholangiocarcinoma, CCF has become the leading global resource for research, education, and public awareness. Chicago was impacted by this rare cancer when Walter Payton lost his battle with cholangiocarcinoma in 1999. Since then, many additional families in the Chicago area have been affected by this rare deadly cancer. As such, CCF will be hosting educational and awareness activities in Chicago during the month of October.

UPCOMING EVENTS:

October 13th - Chicago Marathon: Support and cheer on marathon runners at the
Bank of America Chicago Marathon on Oct. 13. Charity Row Mile 15 - on Adams between Laflin and Loomis. Contact Meredith.McGuffage@cholangiocarcinoma.org for more info.

October 14th - Chicago Cruise for the Cure: Tour the Burnham Park Harbor and support
scholarships for cholangiocarcinoma patients to attend the annual
Cholangiocarcinoma Foundation Conference in April 2020.Contact
Jordan.Giles@cholangiocarcinoma.org or visit https://cholangiocarcinoma.org/chicago-cruise-for-a-cure/ for more info.

October 15th - Regional Symposium: Attend this educational event hosted in
partnership with the University of Chicago. Learn from their hepatobiliary
team about the latest CCA research along with cholangiocarcinoma patient
perspectives. Contact Melinda.Bachini@cholangiocarcinoma.org or visit https://cholangiocarcinoma.org/university-of-chicago-regional-symposium/ for more info.

For more information and photos, please visit our website https://cholangiocarcinoma.org or e-mail rick@cholangiocarcinoma.org

About Cholangiocarcinoma:

Cholangiocarcinoma, a highly lethal cancer with poor prognosis, arises from the bile ducts in the liver. It is often diagnosed at advanced stages when treatment is only minimally effective, emphasizing the imminent need for novel therapies. There are no effective strategies for prevention, early diagnosis or long-term treatment, indicating a significant unmet medical need.

Although considered rare, with 11,000+ cases a year being diagnosed in the US, cholangiocarcinoma is the second most common primary liver cancer in the world. Both incidence and mortality are increasing thus research into this deadly disease is urgently needed.

About the Cholangiocarcinoma Foundation:

Founded in 2006, the Cholangiocarcinoma Foundation is a global 501(c) (3) non-profit organization whose mission is to find a cure and improve the quality of life for those affected by bile duct cancer. For that reason, the Cholangiocarcinoma Foundation continues its efforts to raise awareness of all stakeholders in the cholangiocarcinoma community through advocacy, education, collaboration and research. More information is available at cholangiocarcinoma.org.

Rick Pollock
Cholangiocarcinoma Foundation
+1 888-936-6731
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn